AIRE and autoimmune polyendocrine syndrome type 1: Patients with APS-1, who have germline mutations in the autoimmune regulator (AIRE) gene, are of specific interest as almost all of these individuals have preexisting, extremely high levels of neutralizing antibodies against IFN-I.